The status of STS immunoreactivity tended to be associated with better clinical outcome in 59 NSCLC cases ( P =0.46, Figure 1C ), especially in 44 lung adenocarcinoma cases ( P =0.051, Figure 1D ), but this tendency did not reach statistical significance.
← all excerpts
Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma.
1
—
—